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1. Introduction 
All ophthalmologists and neonatologists are aware that the condition of retinopathy of 
prematurity is potentially blinding to the premature infant. However it is also one of the few 
causes of childhood visual disability which is largely preventable. Many extremely preterm 
infants will develop some degree of retinopathy of prematurity although in the majority this 
never progresses beyond the level of mild disease which resolves spontaneously without 
treatment. A small proportion of premature infants develop potentially severe retinopathy 
which can be detected through retinal screening. If untreated, severe disease can result in 
serious vision impairment and consequently all babies at risk of sight-threatening 
retinopathy of prematurity should be screened.   
2. The aim and importance of screening for retinopathy of prematurity 
Retinopathy of prematurity is a proliferative disease of the retinal vasculature and is a 
potentially blinding disorder of premature infants (Hunter et al. 1992, Gibson et al. 1990). 
The condition is characterized by proliferation of abnormal fibrovascular tissue at the border 
of vascularised and non-vascularised retina (Flyn et al. 1977). Timely and accurate screening 
of this condition is of utmost importance because of the short window of opportunity 
during which treatment is effective. The 1984 Classification of Retinopathy of Prematurity 
(An International Classification of Prematurity, 1984) and the 1988 Cryotherapy for 
Retinopathy of Prematurity (CRYO-ROP) Study (Cryotherapy for retinopathy of 
prematurity cooperative group. 1988) both confirmed the success of treatment for 
retinopathy of prematurity and made screening mandatory. Screening has subsequently 
improved the visual prognosis of this condition. Improved survival of premature infants of 
gestational age less than 25 weeks gestation and very low birth weight has resulted in an 
increased incidence of retinopathy of prematurity and an increase in blindness. These 
factors have significantly increased the importance of screening. Treatment is effective in 
altering the course of the disease and can prevent blindness. This means that screening 
infants is the fundamental first step. The Early Treatment for Retinopathy of Prematurity 
(ETROP) study also confirmed the importance of screening. National based screening 
guidelines have been based on the varied incidence of disease between countries (Early 
Treatment of Retinopathy of Prematurity Cooperative Group. 2003). Many developed 
countries have adopted guidelines and screening criteria based on weight and gestational 
age and these are modified according to population based studies on the incidence of 
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retinopathy of prematurity. There is a varied incidence of the condition in developed 
countries compared to developing countries (Gilbert et al. 1997).The incidence of 
retinopathy of prematurity is much higher in developing countries and there is a greater 
prevalence of the disease in heavier and older premature infants (Phan et al. 2003).  
3. Indications for screening 
Various guidelines for screening of retinopathy of prematurity exist. All guidelines for 
screening are evidence-based.  
3.1 Screening criteria 
The American Academy of Ophthalmology, the American Academy of Paediatrics and the 
American Association of Paediatric Ophthalmology and Strabismus have recommended 
screening infants with birth weights under 1500g or gestational age of 30 weeks or less and 
selected infants with a birth weight between 1500 and 2000g or a gestational age greater 
than 30 weeks with an unstable clinical course who are considered at high risk by their 
paediatrician or neonatologist (2006). In 2007, after an extensive review of the literature, 
updated United Kingdom national guidelines recommended retinopathy of prematurity 
screening for babies of birth weight less than 1501g and / or gestational age less than 32 
weeks (up to 31 weeks and six days)(Royal College of Paediatrics & Child Health & Royal 
College of Ophthalmologists. 2007).  
3.2 Screening protocol 
The American guidelines on screening recommend that in babies born up to 27 weeks the 
first retinopathy of prematurity screen should be performed at 31 weeks post menstrual age. 
Those born at 28 weeks gestation or older are screened at 4 weeks after birth. The United 
Kingdom guidelines recommend that babies born before 27 weeks (up to 26 weeks and 6 
days) the first retinopathy of prematurity screen should be performed at 30 to 31 weeks 
postmenstrual age. Those born at 27 to 31 weeks and 6 days gestational age should have 
their first screen between four to five weeks after birth. It is recommended that repeat 
examinations should take place every two weeks thereafter. However repeat examinations 
should take place weekly when the vessels end in zone 1 or posterior zone 2, there is plus or 
pre plus disease or there is any stage 3 disease in any zone. Of particular importance is the 
retinopathy of prematurity examination at about 34 weeks post menstrual age as this is the 
age at which the risk of severe disease is considered greatest. In countries where resources 
and personnel for screening are scarce, the 34 week screen may be the only examination to 
take place and is also labelled as the one stop examination. Although screening for 
retinopathy in premature babies should follow the above protocol, it is acknowledged that 
there may be clinical or organisational circumstances which prevent this. Where a decision 
is made not to screen a baby, the reason for doing so should be clearly stated in the baby’s 
medical record and the examination should be rescheduled within one week of the intended 
examination. 
3.3 Threshold disease 
The presence of threshold disease signals the need for treatment. Threshold disease is 
defined by the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Study as at least 
five continuous or eight cumulative clock hours of Stage 3 retinopathy of prematurity in 
zone I or II with plus disease. There are other definitions of threshold disease in use, for 
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example, the broader United Kingdom guidelines which in addition to the above also 
include five continuous clock hours or eight cumulative clock hours of stage 3 retinopathy 
of prematurity in zone III with plus disease. The Supplemental Therapeutic Oxygen for 
Prethreshold Retinopathy of Prematurity (STOP-ROP) study had different criteria for zones 
I and II threshold retinopathy of prematurity; for zone II disease it used the same definition 
as the CRYO-ROP study, but in zone I, it defined as 'threshold' any stage of retinopathy of 
prematurity with plus disease, or stage 3 retinopathy of prematurity with or without plus 
disease.   
3.4 Prethreshold disease 
The ETROP study however highlighted the importance of the recognition of prethreshold 
disease and the need for earlier treatment in some babies. This study emphasises the 
importance of pre plus disease and aggressive zone I and zone II retinopathy of prematurity. 
Infants screened prior to 30 weeks gestation have hazy corneas and fundoscopy is more 
difficult. This makes screening prior to 30 weeks difficult and attempting laser treatment is 
almost impossible. The early onset of threshold disease has been referred to as “rush 
disease” by some ophthalmologists. It has been reported at 31 to 32 weeks gestational age 
(Subhani et al. 2001). As a result, the United Kingdom guidelines for screening recommend 
that the more premature infants should undergo the first screening examination at 30 to 31 
weeks post menstrual age. 
 
 
Fig. 1. Classification of treatment guidelines from the Early Treatment of Retinopathy of 
Prematurity (ETROP) Study. 
3.5 Termination of screening 
Screening for retinopathy of prematurity should continue in accordance with the guidelines 
until there is no risk of sight threatening disease. The advice in the UK is to continue 
screening until retinal vascularisation has extended into zone 3 or at 37 weeks in infants in 
whom no retinopathy of prematurity has developed. In infants who have developed 
retinopathy of prematurity, screening may cease once regression has been seen on two 
consecutive examinations. The American guidelines advise ceasing screening when zone 3 
or the entire retina is vascularised, the infant is 45 weeks post menstrual age or the 
retinopathy of prematurity has regressed.   
Early Treatment of Retinopathy of Prematurity (ETROP) 
Classification: 
 
Type 1 ROP should be treated: 
Zone I any stage of ROP with plus disease 
Zone I Stage 3 ROP with or without plus disease 
Zone II Stage 2 or 3 ROP with plus disease 
 
Type 2 should be observed, and only undergo treatment if it progresses 
to type I or threshold disease: 
Zone II Stage 1 or 2 ROP without plus disease 
Zone II Stage 3 ROP without plus disease 
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Screening for retinopathy of prematurity must be safe, cost effective and target those most at 
risk. Effective screening eliminates unnecessary examinations and reduces wastage of 
resources and personnel. Retinopathy of prematurity screening requires experience and 
skill. The ability to recognise severe disease is crucial. All neonatal units should have an 
agreed policy on screening. Screening includes input from the ophthalmologist, 
neonatologist and neonatal nurses. Of great importance is the involvement of the neonatal 
nurses. They play an invaluable role in ensuring infants are included in the screening 
process at the correct gestational age. They ensure that the pupils are dilated prior to the eye 
examination and also assist at examinations. The neonatal nurses also play a key role in 
liaising with both the ophthalmologist and the neonatologist. Screenings should not be 
delayed or missed as this can result in a poorer visual outcome.  
4. The technique of the screening process 
The screening examinations are usually performed in the neonatal unit with the infant in the 
incubator and the trained neonatal staff present. The examination requires a well-dilated 
pupil so that the peripheral retina can be fully visualised. Mydriatic eye drops should be 
instilled approximately 60 minutes and 30 minutes prior to the examination. A combination 
of eye drops is preferable to using one single agent. Various combinations of dilating drop 
regimes exist. Popular combinations include 0.5% cyclopentolate and 2.5% phenylephrine or 
0.5% tropicamide and 2.5% phenylephrine. Most, if not all examinations require a sterile lid 
speculum. An indenting device may be required in some cases to gently rotate or 
manipulate the globe.  
An indirect ophthalmoscope and a hand held 28 or 30 dioptre convex lens are necessary to 
perform the retinal examination. The classification scheme for retinopathy of prematurity 
divides the retina into zones and 12 clock hours and in addition documents the presence or 
absence of plus or pre plus disease. The examiner should therefore be very familiar with a 
visual representation of the zones of the retina.  
The examiner should first visualise the posterior pole looking for retinopathy of prematurity 
and in particular note the presence or absence of plus disease. The posterior pole must be 
scrutinised for flat retinopathy of prematurity and importantly the examiner should be 
aware that advanced disease in this region may not form a ridge. Failure to recognise this 
may lead to a delay in treatment and a poorer visual outcome. The nasal and temporal 
retinal peripheries must then be visualised. 
4.1 Classification of retinopathy of prematurity: zone of retinal involvement   
An important component of the classification of ROP is the zone in which the disease 
occurs. Zone 1 is a circular area, the radius of which is twice the distance from the optic disc 
to the fovea (Fig 2). Zone 11 extends concentrically from the edge of zone 1 and its radius 
extends from the centre of the optic disc to the nasal ora serrata and extends to the equator 
on the temporal side. Zone 111 consists of the residual temporal crescent of retina (Fig 2).  
4.2 Classification of retinopathy of prematurity: the stage of the disease 
The second component of the classification system is the stage of the disease. Stage 1 
retinopathy of prematurity is a thin, flat tortuous, grey-white line that runs approximately 
parallel with the ora serrata and divides the vascular from the avascular retina (Fig 3).  
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Fig. 2. Zones of the retina and clock hours. 
Stage 2 retinopathy of prematurity arises in the region of the line and has height and width 
and extends above the plane of the retina (Fig 4). Stage 3 signifies extra retinal 
neovascularisation (Fig 5). The fibrovascular proliferation extends from the ridge into the 
vitreous, continuous with the posterior aspect of the ridge, causing a ragged appearance as 
the proliferation becomes more extensive. Stage 4a indicates extra foveal retinal detachment 
(Fig 6). Stage 4b indicates macular detachment (Fig 7). The detachment is generally concave 
and circumferentially orientated. In progressive cases the fibrous tissue continues to contract 
and the detachment increases in height and extends posteriorly and anteriorly. Stage 5 (Fig 
8) is present when there is a total retinal detachment and it can be an open or closed funnel 
shape. 
4.3 Plus and pre-plus disease 
The third diagnostic feature is the presence or absence of plus disease which is diagnosed by 
the presence or absence of vessel dilatation and tortuosity (Fig 9), increasing preretinal and 
vitreous haemorrhage, vitreous haze and failure of the pupil to dilate. Plus disease signifies 
a tendency to progression. Pre-plus disease is characterized by abnormal dilatation and 
tortuosity that is insufficient to be designated as plus disease (Fig 10).  
4.4 Stress-reduction techniques 
The retinopathy of prematurity screening examination process can be distressing for the 
infant. Distress can be caused by handling the infant in the incubator, inserting the eyelid 
speculum and use of an indenter to rotate, manipulate or indent the globe. Examinations 
which extend to more than 2 minutes long are not well tolerated by the infant. There is 
conflicting evidence as to the physiological changes which occur secondary to the 
distressing examination. A report by Laws et al. (1996) showed an increase in heart rate of 
seven beats per minute and a 3% drop in oxygen saturation after the examination. However, 
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Slevin et al. (1997) reported no significant change in heart rate or oxygen saturation but 
noted that infants expressed distress by their crying patterns and body and limb 
movements. It was recommended that infants undergoing a screening examination should 
be placed on a soft padded surface with boundaries that maintained them in a flexed 
position but allowed for unrestricted movement of the body and limbs. This method of 
handling may reduce the distress experienced by the infant during the examination process. 
Other comfort care techniques including administering sucrose solution, nesting, swaddling 
and/or the use of a pacifier during the screening examination may also be considered. 
Ophthalmological notes should be made after each screening examination, detailing zone, 
stage, and extent in terms of clock hours of any retinopathy of prematurity and the presence 
of any plus or pre-plus disease. These notes should include a recommendation for the 
timing of the next examination (if any) and be kept with the baby’s medical record. 
4.5 Indirect ophthalmoscopy and retcam digital imaging 
Indirect ophthalmoscopy is recognised as the gold standard for retinopathy of prematurity 
screening. However screening for retinopathy of prematurity with digital imaging has been 
proposed as a potential alternative. The RetCam 120 (Massie Research Laboratory Inc., 
Dublin, California) is a digital retinal camera used frequently in paediatric 
ophthalmology. It is becoming more important for the photo-documentation of retinal 
conditions in infants with retinopathy of prematurity and retinal haemorrhages associated 
with “shaken baby syndrome”. The hand-held camera is placed gently on the cornea 
interfaced with ophthalmic lubricant. It produces excellent reproducible images and its 
advantage over conventional indirect ophthalmoscopy is that of data and image recording 
and also its ease of use. It is also a very gentle examination in comparison to sclera 
indentation. However Adams et al. (2004) reported a case of retinal haemorrhaging after 
RetCam 120 use, highlighting the fragility of the infant retinal vascular system. The 
RetCam can detect disease up to anterior zone 11 which accounts for over 90% of 
retinopathy of prematurity requiring treatment. Despite this, the suitability of the RetCam 
for screening for retinopathy of prematurity, its sensitivity and specificity for detecting 
the various stages of the disease remains underdetermined but is gaining more and more 
acceptance. Yen et al. (2002) concluded that RetCam images had insufficient sensitivity to 
replace the indirect ophthalmoscope. In contrast, Ells et al. (2003) reported that over the 
course of a longitudinal series of examinations that digital photography can identify eyes 
at risk for progression to severe retinopathy of prematurity which would require 
treatment. Based on a pilot study they reported excellent specificity and sensitivity for 
remote detection of severe retinopathy of prematurity using the digitised images which 
were examined remotely by an experienced reader. Wu et al. (2006) compared screening 
and management results recommended by both indirect ophthalmoscopy and RetCam 
users and concluded that digital photography had a sensitivity of 100% and a specificity 
of 97.5%. In 43 infants they noted that screening and management of retinopathy of 
prematurity using RetCam imaging did not fail to detect pre-threshold or threshold disease 
when images could be obtained. However it was noted that indirect ophthalmological 
examinations were required in 20% of cases due to poor image quality or overestimation of 
retinopathy of prematurity.  RetCam digital screening has been used with great success in 
some countries such as Germany.  
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Fig. 3. Stage 1 retinopathy of prematurity. Demarcation line: This is a definite structure that 
separates the avascular from the vascular retina.  
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Fig. 4. Stage 2 Retinopathy of Prematurity. The Ridge: This is the hallmark of the stage 2 
disease. It arises from the demarcation line and has length and width. It extends above the 




Fig. 5. Stage 3 retinopathy of prematurity. Extra retinal fibrovascular proliferation: Extends 
from the ridge into the vitreous. It can be divided into mild, moderate and severe depending 
on vitreous involvement. 
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Fig. 7. Stage 4b retinopathy of prematurity: Foveal partial retinal detachment. 
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Fig. 8. Stage 5 Retinopathy of prematurity: Total retinal detachment. These detachments are 




Fig. 9. Plus disease: These are additional signs indicating the severity of active retinopathy 
of prematurity disease. 1. Venous dilation, anterior tortuosity of posterior pole vessels. 2. Iris 
vascular engorgement. 3. Pupil rigidity. 4. Vitreous haze. 
www.intechopen.com
 Screening for Retinopathy of Prematurity 389 
 
 
Fig. 10. Pre-plus disease: This is defined as vascular abnormality of the posterior pole but 
insufficient to form a diagnosis of plus disease but demonstrates more arterial tortuosity 
and more venous dilation than normal. 
 
 
Fig. 11. Aggressive posterior retinopathy of prematurity. This is a rapidly progressive form of 
retinopathy of prematurity. It can progress to stage 5 retinopathy of prematurity. It has a 
posterior location with prominence of plus disease. It is observed in zone I or posterior zone II. 
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5. Future advances in screening 
The advent of the telemedicine approach to screening in retinopathy of prematurity raises 
some important issues. With increasing survivals and expectations for premature infants 
this is a growing area in terms of litigation. Many ophthalmologists no longer screen for this 
condition and specialist expertise in retinopathy of prematurity staging is frequently not 
available in the peripheral hospitals. The reading of digital images by a remote expert could 
potentially improve the accessibility, quality and cost of retinopathy of prematurity 
management (Richter et al. 2009). There is the potential for trained neonatal nurses to carry 
out retinopathy of prematurity screening examinations safely and effectively with the 
RetCam. This could dramatically reduce the number of indirect ophthalmoscopy 
examinations needed to be carried out. As a result there would be the potential to maximise 
effective screening whilst minimising valuable personnel resource time. Diagnostic accuracy 
and reliability of remote imaging interpretation by experts would have to be assured. 
Lorenz et al. (2009) reported the success with using wide field digital imaging (RetCam 120) 
based telemedicine over a six year period where 1,222 infants were screened. They 
concluded that all treatment requiring retinopathy of prematurity was detected in time with 
sensitivity for detecting suspected treatment-requiring retinopathy of prematurity at 100% 
and a positive predictive value for treatment-requiring retinopathy of prematurity 82.4%. 
This study is a very positive endorsement for the potential future of telemedicine in 
retinopathy of prematurity screening. The RetCam is expensive however and may not be 
cost-effective in those centres where a limited number of infants require screening. 
6. Conclusion 
Screening for retinopathy of prematurity in a timely manner remains the most important 
initial step in the detection and management of the condition. This is of great importance as 
it is acknowledged that earlier treatment of the condition results in improved visual 
outcomes and prognosis. It is becoming increasingly recognized that retinopathy of 
prematurity is a disease for life and there are significant long-term sequelae. All neonatal 
units caring for babies at risk of retinopathy of prematurity should have a written protocol 
in relation to screening. During the screening examination techniques such as nesting the 
baby will reduce the infants stress and pain and this should be encouraged. Training of 
ophthalmologists in the technique of screening for retinopathy of prematurity and the 
recognition of the disease should not be overlooked so that a larger pool of 
ophthalmologists can perform screening in the peripheral hospitals. Whilst indirect 
ophthalmoscopy is the gold standard examination device, RetCam digital image systems are 
becoming increasingly important. The application of telemedicine to retinopathy of 
prematurity screening is encouraging and positive and in larger neonatal units telemedicine 
may almost certainly play a much bigger role in the future. 
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